Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide
Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, Xu XN
AOD 9604 does not interact with growth hormone receptors, does not affect insulin signaling, and does not cross into the central nervous system to alter appetite or mood
Results typically last 6 to 12 months, depending on age, lifestyle, and treatment area
Benefit #1: Enhanced Cellular Energy Metabolism (Strongest Evidence) Evidence Quality: Human and animal studies Mechanism: NAD+ restoration and improved mitochondrial function The most robust benefit of 5-amino-1MQ is metabolic enhancement through cellular energy optimization